K031-120
Showing 1 - 25 of 8,793
COVID-19 Symptoms in "Long Hauler" Patients Who Participated in
Completed
- COVID-19
- KB109 + Self Supportive Care
- Self Supportive Care (SSC) Alone
-
Hot Springs, Arkansas
- +1 more
Aug 17, 2021
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Atlanta, Columbus (drug, biological,
Completed
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +8 more
- PI3K inhibitor BKM120
- +3 more
-
Atlanta, Georgia
- +1 more
Jun 27, 2022
Esophageal Cancer Trial in Hat yai (BKM120)
Terminated
- Esophageal Cancer
-
Hat yai, Songkhla, ThailandSongklanagarind Hospital, Prince of Songkla University
Oct 3, 2021
Solid Tumor, Adult Trial in Shanghai, Hangzhou (HF1K16 /Arm 45 mg/m2, HF1K16 /Arm 90 mg/m2, HF1K16 /Arm 120 mg/m2)
Recruiting
- Solid Tumor, Adult
- HF1K16 /Arm 45 mg/m2
- +3 more
-
Shanghai, Shanghai, China
- +2 more
May 23, 2022
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +35 more
- PI3K inhibitor BKM120
- cetuximab
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Sep 14, 2021
NonSegmental Vitiligo Trial in Canada, United States (INCB054707, Placebo)
Active, not recruiting
- NonSegmental Vitiligo
- INCB054707
- Placebo
-
Hoover, Alabama
- +30 more
Nov 14, 2022
Chronic Kidney Disease Trial in Worldwide (Placebo, AST-120)
BRAF Mutant Metastatic Melanoma Trial in San Francisco (BKM120 Combined with Vemurafenib (PLX4032))
Completed
- BRAF Mutant Metastatic Melanoma
- BKM120 Combined with Vemurafenib (PLX4032)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 6, 2020
Advanced Gastric Adenocarcinoma Trial in Seoul (GSK2636771, Paclitaxel)
Completed
- Advanced Gastric Adenocarcinoma
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System, Yonsei Canc
Apr 21, 2021
Chronic Plaque Psoriasis Trial in Canada, United States (ARQ-151 0.3% cream, ARQ-151 vehicle cream)
Completed
- Chronic Plaque Psoriasis
- Roflumilast 0.3% cream
- Vehicle Cream
-
Encinitas, California
- +39 more
Dec 5, 2022
Chronic Hand Eczema Trial in Worldwide (Delgocitinib cream, Cream vehicle)
Completed
- Chronic Hand Eczema
- Delgocitinib cream
- Cream vehicle
-
Calgary, Alberta, Canada
- +53 more
Nov 1, 2022
Lanreotide Autogel® 120 mg in Locally Advanced or Metastatic
Withdrawn
- Neuroendocrine Tumors
-
Gdańsk, Poland
- +10 more
Nov 4, 2020
INNOVA Stent for Femoropopliteal Artery Disease:
Unknown status
- Femoropopliteal Artery Disease
- innova stent (Boston scientific)
-
Seoul, Korea, Republic ofSeverance Hospital
Sep 25, 2020
Idiopathic Parkinson's Disease Trial in United States (CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]), Sham
Completed
- Idiopathic Parkinson's Disease
- CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN])
- Sham Surgery
-
Birmingham, Alabama
- +8 more
Nov 8, 2022
Liver Transplant; Complications, Drainage Trial (Abdominal drainage)
Not yet recruiting
- Liver Transplant; Complications
- Drainage
- Abdominal drainage
- (no location specified)
Jan 14, 2023
Chronic Endometritis Trial in Beijing (Antibiotics)
Completed
- Chronic Endometritis
-
Beijing, Beijing, ChinaFuXing Hospital,Capital Medical University
Feb 3, 2022
Chorea Associated With Huntington Disease Trial in Australia, Canada, United States (SD-809)
Completed
- Chorea Associated With Huntington Disease
-
Birmingham, Alabama
- +37 more
Nov 5, 2021
Systemic Lupus Erythematosus Trial in Worldwide (BOS161721, Placebo)
Chronic Spontaneous Urticaria Trial in Worldwide (Ligelizumab, Omalizumab, Placebo)
Completed
- Chronic Spontaneous Urticaria
- Ligelizumab
- +2 more
-
Gilbert, Arizona
- +160 more
Dec 12, 2022